A COHORT STUDY COMPARING THE DETECTION OF HPV DNA FROM WOMEN WHO STOP AND CONTINUE TO SMOKE

被引：8

作者：

FAIRLEY, CK ^{[1
]}

TABRIZI, SN ^{[1
]}

GOURLAY, SG ^{[1
]}

CHEN, SJ ^{[1
]}

BORG, A ^{[1
]}

GARLAND, SM ^{[1
]}

机构：

[1] ROYAL HOSP WOMEN,DEPT MICROBIOL,CARLTON,VIC 3053,AUSTRALIA

来源：

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY | 1995年 / 35卷 / 02期

关键词：

D O I：

10.1111/j.1479-828X.1995.tb01865.x

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The objective of this study was to compare the detection of human papillomavirus (HPV) DNA in women who stopped smoking, and those who continued to smoke. Women entering a smoking cessation programme had tampon specimens collected and analyzed for HPV DNA using polymerase chain reaction (PCR) (L1 consensus primers). Women with HPV DNA in their initial specimens had follow-up specimens collected 1 year later. The stored initial specimens were reanalyzed in the same experiment with the follow-up specimen. In addition, Hybrid Capture and quantitative PCR were used to determine if the change in HPV DNA over the year of follow-up was greater in either group. Of 197 women who were recruited into the study, 57 (29%) were positive for HPV DNA. Second specimens were obtained from 49 of these 57 women. Of these 49 women, 13 had stopped smoking and 36 continued to smoke. The detection of HPV DNA in follow-up specimens was not significantly different in the women who stopped smoking (54%) compared to those who continued to smoke (50%, p = 0.81). Furthermore, the change in the amount of HPV DNA during follow-up was not different in women who stopped smoking compared to women who continued to smoke (p > 0.25). This study suggests that smoking cessation does not affect the detection of genital HPV DNA. On the basis of these findings it is likely that smoking does not increase the risk of invasive cervical cancer by prolonging the detection of HPV DNA.

引用

页码：181 / 185

页数：5

共 15 条

[1] Brinton LA., Epidemiology of cervical cancer‐overview, The epidemiology of human papillomavirus and cervical cancer, pp. 3-22, (1992)
[2] Koutsky LA, Holmes KK, Critehlow CW, Et al., A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection, N Engl J Med, 327, pp. 1272-1278, (1992)
[3] Gourlay SG, Forbes A., Marriner T., Pethica D., McNeil JJ., AGAIN Study Phase I: A prospective study of factors predicting smoking cessation using transdermal nicotine therapy, BMJ, 309, pp. 842-846, (1994)
[4] Fairley CK, Chen S., Tabrizi SN, Quinn M., McNeill JJ, Garland SM., A novel method for the assessment of human papillomavirus infection, J Infect Dis, 165, pp. 1103-1106, (1992)
[5] Manos MM, Ting Y., Wright DK, Lewis AJ, Broker TR, Wolinsky SM., The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses, Cancer Cells, 7, pp. 209-214, (1989)
[6] Resnick RM, Cornelissen MT, Wright DK, Et al., Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl, Cancer Inst., 82, pp. 1477-1484, (1990)
[7] Ley C., Bauer HM, Regingold A., Et al., Determinants of genital human papillomavirus infection in young women, J Nat Cancer Inst., 83, pp. 997-1003, (1991)
[8] Fairley CK, Chen S., Ugoni A., Tabrizi SN, Forbes A., Garland SM.
[9] Burk RD, Kadish AS, Calderin S., Rommney SL., Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: Correlation with biopsy results and Papanicolaou smear, Am J Obstet Gynecol, 154, pp. 982-989, (1986)
[10] Rohan T., Mann V., McLaughlin J., Et al., PCR‐detected genital papillomavirus infection: Prevalence and association with risk factors for cervical cancer, Int J Cancer, 49, pp. 856-860, (1991)

← 1 2 →